IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,185,216 | +692.0% | 317,406 | +291.4% | 0.29% | +775.8% |
| Q2 2023 | $1,538,467 | -41.7% | 81,100 | -52.3% | 0.03% | -38.9% |
| Q1 2023 | $2,638,251 | -15.7% | 170,100 | -3.6% | 0.05% | -25.0% |
| Q4 2022 | $3,130,887 | +294.8% | 176,388 | +24.1% | 0.07% | +260.0% |
| Q3 2022 | $793,000 | +183.2% | 142,135 | +341.0% | 0.02% | +150.0% |
| Q3 2021 | $280,000 | -77.3% | 32,233 | -72.4% | 0.01% | -79.5% |
| Q2 2021 | $1,234,000 | -6.5% | 116,759 | +308.7% | 0.04% | -20.4% |
| Q4 2020 | $1,320,000 | -3.9% | 28,568 | -26.8% | 0.05% | -41.0% |
| Q3 2020 | $1,374,000 | +58.8% | 39,032 | +9.9% | 0.08% | +40.7% |
| Q2 2020 | $865,000 | -53.5% | 35,507 | -70.3% | 0.06% | -61.7% |
| Q1 2020 | $1,862,000 | +38.5% | 119,604 | +41.3% | 0.15% | +31.6% |
| Q4 2019 | $1,344,000 | – | 84,663 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |